top of page
MABTHERA SOLUTION FOR SUBCUTANEOUS INJECTION 1400MG
Product details
Registration number: SIN15023P
Classification: Prescription Only
Active ingredients: Rituximab
Strength: 1400mg
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Registrant: ROCHE SINGAPORE PTE. LTD.
ATC code: L01XC02
HSA approval date: 1 June 2016
Manufacturer(s): F. Hoffmann-La Roche Ltd
Manufacturing country/countries: SWITZERLAND
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
bottom of page
.png)